Status:
WITHDRAWN
Multimodal Pain Therapy After Hernia Repair
Lead Sponsor:
Khashayar Vaziri
Conditions:
Hernia, Abdominal
Pain
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
Investigating the effect of multimodal pain treatment after hernia repair
Detailed Description
This is a randomized, non-blinded study comparing the effects of multimodal pain management (ibuprofen, tylenol, and narcotics/oxycodone as needed) for relief of post-operative pain in patients who un...
Eligibility Criteria
Inclusion
- Healthy adult patients \>18 years of age to 90 years of age who are eligible for a hernia repair (ventral or inguinal) by a surgeon in the Medical Faculty Associates Department of General Surgery at the George Washington University Hospital.
Exclusion
- Patients with allergies to sulfa or any of the medications being evaluated in this study (ibuprofen, tylenol, oxycodone)
- patients with a history of gastric ulcer or gastrointestinal bleeding
- patients with kidney disease
- patients with cardiovascular disease
- patients with a co-morbid condition that would prohibit them from taking narcotics
- patients with known or suspected narcotic abuse
- patients who do not wish to participate
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03792295
Start Date
July 1 2021
End Date
July 1 2022
Last Update
August 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George Washington University Hospital
Washington D.C., District of Columbia, United States, 20037